Comparison of the efficacy and safety of first-line treatments based on clinicopathological characteristics for patients with advanced epidermal growth factor receptor mutated non-small-cell lung cancer: A systematic review and network meta-analysis
Fei Yang, Wengang Zhang, Xiaoling Shang, Geoffrey Liu, Xinchun Ma, Jing Qin, Yuqing Zhang, Yanguo Liu, Xiuwen Wang
Topics & Concepts
MedicineInternal medicineOsimertinibOncologyGefitinibLung cancerEpidermal growth factor receptorRegimenPemetrexedAdverse effectProgression-free survivalClinical endpointErlotinibRandomized controlled trialCochrane LibraryChemotherapyCancerCisplatinLung Cancer Treatments and MutationsCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and Treatment